111 related articles for article (PubMed ID: 24318893)
1. Discovery of small molecule modifiers of microRNAs for the treatment of HCV infection.
Tripp VT; Young DD
Methods Mol Biol; 2014; 1103():153-63. PubMed ID: 24318893
[TBL] [Abstract][Full Text] [Related]
2. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.
Young DD; Connelly CM; Grohmann C; Deiters A
J Am Chem Soc; 2010 Jun; 132(23):7976-81. PubMed ID: 20527935
[TBL] [Abstract][Full Text] [Related]
3. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection.
Pfeffer S; Baumert TF
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):431-5. PubMed ID: 20537478
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-122 as a therapeutic target for oligonucleotides and small molecules.
Thomas M; Deiters A
Curr Med Chem; 2013; 20(29):3629-40. PubMed ID: 23745562
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and human miR-122: insights from the bench to the clinic.
Wilson JA; Sagan SM
Curr Opin Virol; 2014 Aug; 7():11-8. PubMed ID: 24721497
[TBL] [Abstract][Full Text] [Related]
6. Discovering the first microRNA-targeted drug.
Lindow M; Kauppinen S
J Cell Biol; 2012 Oct; 199(3):407-12. PubMed ID: 23109665
[TBL] [Abstract][Full Text] [Related]
7. Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy.
Motavaf M; Safari S; Alavian SM
Acta Virol; 2014; 58(4):301-8. PubMed ID: 25518710
[TBL] [Abstract][Full Text] [Related]
8. [The influence of small regulatory RNAs on the viral infection--new strategies in HCV therapy].
Figlerowicz M; Tyczewska A; Figlerowicz M
Przegl Epidemiol; 2006; 60(4):693-700. PubMed ID: 17682750
[TBL] [Abstract][Full Text] [Related]
9. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function.
Connelly CM; Thomas M; Deiters A
J Biomol Screen; 2012 Jul; 17(6):822-8. PubMed ID: 22412086
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy.
Hoffmann TW; Duverlie G; Bengrine A
Virol J; 2012 Jun; 9():109. PubMed ID: 22691570
[TBL] [Abstract][Full Text] [Related]
11. Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids.
Machlin ES; Sarnow P; Sagan SM
Curr Gene Ther; 2012 Aug; 12(4):301-6. PubMed ID: 22856605
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the hepatitis C virus genome replication by miR-199a.
Murakami Y; Aly HH; Tajima A; Inoue I; Shimotohno K
J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
[TBL] [Abstract][Full Text] [Related]
13. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
Ishida H; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Biochem Biophys Res Commun; 2011 Aug; 412(1):92-7. PubMed ID: 21802413
[TBL] [Abstract][Full Text] [Related]
14. Development of microRNA therapeutics is coming of age.
van Rooij E; Kauppinen S
EMBO Mol Med; 2014 Jul; 6(7):851-64. PubMed ID: 24935956
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus and microRNAs: miRed in a host of possibilities.
Singaravelu R; Russell RS; Tyrrell DL; Pezacki JP
Curr Opin Virol; 2014 Aug; 7():1-10. PubMed ID: 24721496
[TBL] [Abstract][Full Text] [Related]
16. miRNA Targeting Drugs: The Next Blockbusters?
Schmidt MF
Methods Mol Biol; 2017; 1517():3-22. PubMed ID: 27924471
[TBL] [Abstract][Full Text] [Related]
17. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Jopling CL; Norman KL; Sarnow P
Cold Spring Harb Symp Quant Biol; 2006; 71():369-76. PubMed ID: 17381319
[TBL] [Abstract][Full Text] [Related]
18. Macro and small over micro: macromolecules and small molecules that regulate microRNAs.
Kang S; Im K; Baek J; Yoon S; Min H
Chembiochem; 2014 May; 15(8):1071-8. PubMed ID: 24797338
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of microRNAs in cancer.
Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
[TBL] [Abstract][Full Text] [Related]
20. Antisense inhibitors, ribozymes, and siRNAs.
Thompson AJ; Patel K
Clin Liver Dis; 2009 Aug; 13(3):375-90. PubMed ID: 19628155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
